Startups
sutro
Congrats to Sutro Bio on their recent IPO! In full disclosure, I have been a fan of this concept from the early days, investing in their spinout from Stanford in 2004, and then the subsequent four rounds over the past 14 years. It took a while to optimize this technology, but now I see new high-volume opportunities in protein synthesis to feed the clean lab meat industry. I saw this slide of the growing landscape in the Cell-Free Synthesis section of SynBioBeta earlier this month. SynBio Prof. Paul Freemont from Imperial College introduced Sutro as “the great pioneer of cell-free systems.” And Thomas Meany, CEO of Cell-Free Technology, presented: “DNA to protein TX/TL apparatus is 100x faster outside the cell, because there is no cell wall.” Surto’s focus to date has been on manufacturing
Team
No team members on record yet.